HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
V Silingardi Selected Research
V Silingardi Research Topics
Disease
2
Breast Neoplasms (Breast Cancer)
09/2002 - 05/2000
2
Lymphoma (Lymphomas)
11/2000 - 03/2000
1
Varicocele
08/2005
1
Carcinoma (Carcinomatosis)
09/2002
1
Disease Progression
05/2000
1
Circulating Neoplastic Cells
05/2000
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
03/2000
1
Myocardial Infarction
03/2000
1
Neoplasms (Cancer)
02/2000
1
Diarrhea
01/2000
1
Colorectal Neoplasms (Colorectal Cancer)
01/2000
Drug/Important Bio-Agent (IBA)
1
Nitric Oxide (Nitrogen Monoxide)
FDA Link
08/2005
1
Dacarbazine (DIC)
FDA Link
Generic
09/2002
1
Nonsense Codon (Nonsense Mutation)
IBA
09/2002
1
Plastics
IBA
11/2000
1
Immunosorbents
IBA
11/2000
1
Enzymes
IBA
11/2000
1
Protease Inhibitors (Protease Inhibitor)
IBA
05/2000
1
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
05/2000
1
Messenger RNA (mRNA)
IBA
05/2000
1
SERPIN-B5 (maspin)
IBA
05/2000
1
Serpins
IBA
05/2000
1
Proteins (Proteins, Gene)
FDA Link
05/2000
1
Pharmaceutical Preparations
IBA
03/2000
1
Progesterone Receptors (Progesterone Receptor)
IBA
02/2000
1
Estrogens (Estrogen)
FDA Link
02/2000
1
Loperamide (Imodium)
FDA Link
Generic
01/2000
1
Somatostatin (Somatotropin Release-Inhibiting Factor)
IBA
01/2000
1
Octreotide (Sandostatin)
FDA Link
Generic
01/2000
Therapy/Procedure
4
Drug Therapy (Chemotherapy)
11/2000 - 01/2000
2
Therapeutics
05/2000 - 03/2000
1
PROMACE-CytaBOM protocol
03/2000